Related Experiment Videos
Cancer chemotherapy in the elderly.
American Family Physician
|March 1, 1987
Summary
Elderly patients with good performance status can safely receive chemotherapy for responsive cancers, improving survival and quality of life. Doses of certain chemotherapy drugs should be adjusted in older adults due to age-related physiological changes.
Area of Science:
- Geriatric oncology
- Clinical pharmacology
Background:
- Aging impacts physiological reserve across multiple organ systems.
- Chemotherapy in elderly patients requires careful consideration of potential toxicities.
Purpose of the Study:
- To evaluate the feasibility and benefits of chemotherapy in elderly patients with good performance status.
- To identify specific drug classes and physiological factors necessitating dose adjustments in older adults.
Main Methods:
- Review of clinical data on chemotherapy use in elderly cancer patients.
- Analysis of age-related changes in organ function (e.g., renal, cardiac).
Main Results:
- Elderly patients with good performance status tolerate chemotherapy well for responsive neoplasms.
- Improved survival and quality of life observed in treated patients.
- Age-related decline in glomerular filtration rate and cardiac reserve necessitates dose reduction for renally excreted drugs and anthracyclines.
Conclusions:
- Chemotherapy is a viable option for select elderly cancer patients, enhancing outcomes.
- Personalized dosing strategies are crucial to mitigate toxicity in geriatric oncology.
- Careful management of age-related physiological decrements is essential for safe and effective cancer treatment in the elderly.